DOSIMETRIC COMPARISON OF INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND VOLUMETRIC-MODULATED ARC THERAPY (VMAT) IN RECTAL CANCER PATIENTS: A COMPREHENSIVE ANALYSIS

S SHAFIQUE; K KHAN; T BAIDAR; M OKASHA

doi:10.54112/bcsrj.v2024i1.753

Authors

S SHAFIQUE Department of Radiation Oncology, Combined Military Hospital (CMH), Rawalpindi, Pakistan
K KHAN Department of Mediciine, Combined Military Hospital (CMH), Rawalpindi, Pakistan
T BAIDAR Department of Mediciine, Shaukat Khanum Cancer Memorial Hospital & Research Centre, Peshawar, Pakistan
M OKASHA Department of Mediciine, Ashfaq Hospital, Rawalpindi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.753

Keywords:

Dose-Response Relationship, Radiation, Intensity-Modulated Radiation Therapy, Neoplasm Staging, Rectal Neoplasms, Radiotherapy Dosage

Abstract

This study aimed to conduct a thorough dosimetric comparison between two advanced radiotherapy techniques, Intensity-Modulated Radiation Therapy (IMRT) and Volumetric-Modulated Arc Therapy (VMAT), to ascertain the superior modality in terms of dose distribution and organ-at-risk sparing for rectal cancer patients. Thirty-three patients with ECOG performance status 1, aged between 18 to 60 years, diagnosed with Stage II to III rectal cancer, were included in this prospective study. Each patient underwent treatment planning with IMRT and VMAT techniques using Varian system simulation computed tomography scans. The dosimetric analysis encompassed the evaluation of target volume dose homogeneity, conformity, and doses to at-risk organs. The dosimetric comparison was conducted utilizing seven-field IMRT and dual arc VMAT plans. Statistical analysis was performed using paired t-tests and SPSS 20 software. Treatment plan constraints adhered to the RTOG 9406 guidelines, ensuring adequate planning target volume (PTV) coverage, homogeneity index, conformity index, and dose limits for organs at risk, including small bowel V20 (<200cc), bladder V45 (<21Gy), and femoral head V50 (≤30 Gy). Volumetric arc therapy plans demonstrated superior dose homogeneity to fixed-field intensity-modulated plans (p-value = 0.04), particularly in femoral head dose-limiting toxicity (p-value = 0.00). However, intensity-modulated therapy exhibited equivalent or superior performance in other evaluated parameters. Our findings suggest that while VMAT offers advantages in PTV coverage homogeneity and femoral head dose-limiting toxicity, IMRT remains competitive and potentially preferable in certain dosimetric aspects. The choice between IMRT and VMAT should be carefully considered based on individual patient characteristics and treatment goals. This comprehensive dosimetric comparison contributes valuable insights into optimizing radiotherapy planning for rectal cancer patients, potentially guiding clinical decision-making and improving treatment outcomes.

Downloads

Download data is not yet available.

References

Ballhausen, H., Li, M., Ganswindt, U., and Belka, C. (2018). Shorter treatment times reduce the impact of intra-fractional motion. Strahlentherapie und Onkologie 194, 664-674.

Ingle, M., White, I., Chick, J., Stankiewicz, H., Mitchell, A., Barnes, H., Herbert, T., Nill, S., Oelfke, U., and Huddart, R. (2023). Understanding the benefit of magnetic resonance-guided adaptive radiotherapy in rectal cancer patients: a single-centre Study. Clinical Oncology 35, e135-e142.

Kaplan, S. O., Akbörü, H., Sarali, Y., Altin, S., and Ünsal, M. (2019). Dosimetric Comparison of Intensity-Modulated Radiotherapy and Volumetric Arc Therapy for Rectal Cancer. Turkish Journal of Oncology 34.

Kryger, M., Wang, W., Wu, S., Xue, J., Cheng, P., Das, I., and Hu, K. (2017). A comparison of IMRT and VMAT treatment planning for head and neck cancer with NTCP/TCP analysis. International Journal of Radiation Oncology, Biology, Physics 99, E680.

Latkauskas, T., Pauzas, H., Kairevice, L., Petrauskas, A., Saladzinskas, Z., Janciauskiene, R., Gudaityte, J., Lizdenis, P., Svagzdys, S., and Tamelis, A. (2016). Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. BMC cancer 16, 1-7.

Rossi, M., Boman, E., and Kapanen, M. (2019). Contralateral tissue sparing in lymph node-positive breast cancer radiotherapy with VMAT technique. Medical Dosimetry 44, 117-121.

Sauer, R., Liersch, T., Merkel, S., Fietkau, R., Hohenberger, W., Hess, C., Becker, H., Raab, H.-R., Villanueva, M.-T., and Witzigmann, H. (2012). Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin oncol 30, 1926-1933.

Shi, J., Yang, F., Ju, X., Huang, Y., and Jiang, F. (2017). Comparative study on dosimetry of VMAT and IMRT in assisted radiotherapy after radical resection of rectal cancer. Oncology letters 13, 2971-2974.

Wang, R., Shen, J., Yan, H., Gao, X., Dong, T., Li, S., Wang, P., and Zhou, J. (2022). Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy: CONSORT. Medicine 101, e28427.

Xu, D., Li, G., Li, H., and Jia, F. (2017). Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: a systematic review and meta-analysis. Medicine 96, e7685.

Yang, Y., Liu, Q., Jia, B., Du, X., Dai, G., Liu, H., Chen, J., Zeng, M., Wen, K., and Zhu, Y. (2019). Preoperative volumetric modulated arc therapy with simultaneous integrated boost for locally advanced distal rectal cancer. Technology in Cancer Research & Treatment 18, 1533033818824367.

Zhao, J., Hu, W., Cai, G., Wang, J., Xie, J., Peng, J., and Zhang, Z. (2016). Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost. Oncotarget 7, 6345.